| LC and LC–MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway L Mehta, T Naved, P Grover, M Bhardwaj, D Mukherjee Journal of Pharmaceutical and Biomedical Analysis 194, 113768, 2021 | 27 | 2021 |
| LC-MS/MS studies for identification and characterization of new forced degradation products of dabrafenib and establishment of their degradation pathway P Grover, M Bhardwaj, L Mehta Journal of Pharmaceutical and Biomedical Analysis 206, 114351, 2021 | 14 | 2021 |
| Identification and characterization of new degradation products of belinostat using UHPLC-Q-TOF-MS/MS and in silico toxicity prediction L Mehta, T Naved, P Grover, M Bhardwaj, D Mukherjee, DR Vennapu Journal of Liquid Chromatography & Related Technologies 44 (5-6), 285-297, 2021 | 14 | 2021 |
| Analytical method development and validation for assay of rufinamide drug J Singh, S Sangwan, P Grover, L Mehta, D Kiran, A Goyal Journal of Pharmaceutical Technology, Research and Management 1 (2), 191-203, 2013 | 12 | 2013 |
| Current developments in the pyran-based analogues as anticancer agents P Grover, M Bhardwaj, L Mehta, G Kapoor, PA Chawla Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal …, 2022 | 11 | 2022 |
| Development and validation of novel and highly sensitive stability-indicating reverse phase ultra performance liquid chromatography method for quantification of Ibrutinib and … L Mehta, T Naved, P Grover, M Bhardwaj, D Mukherjee Indian Journal of Pharmaceutical Sciences 82 (6), 958-966, 2020 | 11 | 2020 |
| Advances on quinazoline based congeners for anticancer potential P Grover, M Bhardwaj, G Kapoor, L Mehta, R Ghai, K Nagarajan Current Organic Chemistry 25 (6), 695-723, 2021 | 8 | 2021 |
| Development and validation of novel and highly sensitive stability-indicating reverse phase UPLC method for quantification of Dabrafenib and its ten degradation products P Grover, M Bhardwaj, L Mehta, T Naved, V Handa Indian Journal of Pharmaceutical Education and Research 56 (3), 888-98, 2022 | 7 | 2022 |
| Identification and characterization of in vitro metabolites of belinostat by rat liver microsomes using ultra performance liquid chromatography coupled with tandem mass … P Grover, L Mehta, T Naved, S Kumar, G Monga Indian Journal of Pharmaceutical Education and Research 56 (1), S58-S66, 2022 | 7 | 2022 |
| Metabolite detection and profiling using analytical methods L Mehta, P Grover, T Naved, D Mukherjee Current Pharmaceutical Analysis 17 (1), 2-9, 2021 | 7 | 2021 |
| Identification and Characterization of In Vitro Metabolites of Ibrutinib by Rat Liver Microsomes Using Ultra-Performance Liquid Chromatography Coupled with Tandem Mass … P Grover, M Bhardwaj, L Mehta, T Naved, S Kumar Indian Journal of Pharmaceutical Sciences 84 (3), 2022 | 6 | 2022 |
| Piperidine nucleus as a promising scaffold for alzheimer’s disease: current landscape and future perspective P Grover, S Rohilla, M Bhardwaj, L Mehta, A Malhotra Current Topics in Medicinal Chemistry 23 (13), 1221-1259, 2023 | 5 | 2023 |
| Exploring the multitarget potential of iridoids: advances and applications P Grover, L Mehta, A Malhotra, G Kapoor, K Nagarajan, P Kumar, ... Current Topics in Medicinal Chemistry 23 (5), 371-388, 2023 | 5 | 2023 |
| Potential role of nicotinamide analogues against SARS-COV-2 target proteins MK Arora, P Grover, SMB Asdaq, L Mehta, R Tomar, M Imran, A Pathak, ... Saudi Journal of Biological Sciences 28 (12), 7567-7574, 2021 | 5 | 2021 |
| RP-HPLC Method Development and Validation for the Determination of Bupropion Hydrochloride in a Solid Dosage Form L Mehta, J Singh Res. Rev. J. Pharm. Anal 2 (3), 1-5, 2013 | 5 | 2013 |
| Development and validation of a stability-indicating method for neostigmine bromide: separation, identification and characterization of degradation product using LC-MS and ESI … R Makkar, J Singh, M Bhardwaj, L Mehta, P Grover Indian Journal of Pharmaceutical Sciences 56, 1-13, 2022 | 4 | 2022 |
| LC and LC-MS/MS studies for identification and characterization of degradation products of d-tubocurarine chloride P Grover, S Maheshwari, K Nagarajan, L Mehta, S Kumar, C Rastogi Journal of Pharmaceutical and Biomedical Analysis 223, 115119, 2023 | 3 | 2023 |
| Targeted delivery approaches for synthesis of plant based nanoparticles as anticancer chemotherapeutics P Grover, L Mehta, K Nagarajan, P Kumar, A Pathak, K Sharma Materials Today: Proceedings 64, 1193-1196, 2022 | 1 | 2022 |
| Network pharmacology approach to reveal the antiosteosarcoma mechanism of berberine P Grover, L Mehta, M Bhardwaj, K Nagarajan Recent Trends in Communication and Electronics, 448-451, 2021 | 1 | 2021 |
| Synthetic modification of β-sitosterol with 2-amino-1, 3, 4, 6-tetra-O-hydroxy-2-deoxy-β-D-glucopyranose hydrochloride P Grover, J Singh, KL Dhar, L Mehta Journal of the Indian Chemical Society 86 (10), 1112-1114, 2009 | 1 | 2009 |
Dr. Parul GroverAssociate Professor, KIET School of PharmacyVerified email at kiet.edu
